Luke R. G. Pike

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Luke R. G. Pike

Jul 25, 2024, 21:48 | Insight

Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?

Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…

Jul 25, 2024, 14:02 | Insight

Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?

Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…

Jul 24, 2024, 05:00 | Blog

Clinical Validation of a Cell-free DNA assay for Early Lung Cancer Detection

Memorial Sloan Kettering Radiation Oncology shared on X: "New in Cancer Discovery from The Pike…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023